Evidence map›Paper›PMID 38654328›Full record

ReviewCell communication and signaling : CCS2024

A promising frontier: targeting NETs for stroke treatment breakthroughs.

Huijie Fang, Yunfei Bo, Zhongfei Hao, Ge Mang, Jiaqi Jin, Hongjun Wang

Open access · goldAbstract readReview
In one paragraph

Review in Cell communication and signaling : CCS, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Identification of NETs-related genes as diagnostic biomarkers in ischemic stroke using RNA sequencing and single-cell analysis.Mammalian genome : official journal of the International Mammalian Genome Society · 2025
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Huijie FangDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Yunfei BoDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Zhongfei HaoDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150001, China.
Ge MangDepartment of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Jiaqi JinDepartment of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. 18845893640@163.com.
Hongjun WangDepartment of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150001, China. wanghongjun@163.com.
Second Affiliated Hospital of Harbin Medical University · CNHarbin Medical University · CNCapital Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke is a prevalent global acute cerebrovascular condition, with ischaemic stroke being the most frequently occurring type. After a stroke, neutrophils accumulate in the brain and subsequently generate and release neutrophil extracellular traps (NETs). The accumulation of NETs exacerbates the impairment of the blood‒brain barrier (BBB), hampers neovascularization, induces notable neurological deficits, worsens the prognosis of stroke patients, and can facilitate the occurrence of t-PA-induced cerebral haemorrhage subsequent to ischaemic stroke. Alternative approaches to pharmacological thrombolysis or endovascular thrombectomy are being explored, and targeting NETs is a promising treatment that warrants further investigation.

Indexed as

Extracellular TrapsStrokeAnimalsBlood-Brain BarrierHumansNeutrophilsIschaemic strokeNeutrophilNeutrophil extracellular trapt-PA

Identifiers

PMID38654328
PMCPMC11036592
OpenAlexW4395039942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.